BMC Cancer (Oct 2019)

Predictive factors of disease-free survival after complete pathological response to neoadjuvant radiotherapy for rectal adenocarcinoma: retrospective case series

  • Amine Souadka,
  • Mohammed Anass Majbar,
  • Amine Benkabbou,
  • Badr Serji,
  • Tarik Souiki,
  • Sidi Mohammed Bouchentouf,
  • Mourad Abid,
  • Basma El Khannousi,
  • Tijani El Harroudi,
  • Hadj Omar El Malki,
  • Mohammed Raiss,
  • Lahsen Ifrine,
  • Khalid Mazaz,
  • Aziz Zentar,
  • Raouf Mohsine,
  • Abdelilah Souadka,
  • Abdelkader Belkouchi,
  • Mohammed Ahallat,
  • Abdelmalek Hrora,
  • on behalf of the Moroccan Society of Surgery

DOI
https://doi.org/10.1186/s12885-019-6239-3
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Background Many data suggest that patients with low rectal adenocarcinoma who achieved ypT0N0 status have improved survival and disease-free survival (DFS) compared to all other stages however only few data are available regarding the specific prognosis factors of this subgroup. This study aimed to evaluate predictive factors for disease free survival after complete pathological response (CPR) in cases of low rectal adenocarcinoma. Materials and methods From January 2005 to December 2013, all patients with low rectal adenocarcinoma who underwent neoadjuvant chemoradiotherapy followed by total mesorectal excision and achieved CPR were included at 7 Moroccan and 1 Algerian centres. Predictive factors for disease-free survival were analysed by uni and multivariate analysis. Results Eigthy-four (12.1%) patients achieved a CPR (ypT0N0). Multivariate analysis revealed that both poorly differentiated tumors (OR, 9.23; 95 CI 1.35–62.82; P = 0.023) and the occurrence of perineal sepsis (OR, 13.51; 95 CI 1.96–93.12; P = 0.008) were independently associated with impaired DFS. Conclusions Patients with low rectal cancer who exhibited a CPR after neoadjuvant therapy have good prognoses; however, the occurrence of perineal sepsis and/or poor initial differentiation may be associated with impaired DFS in these patients. Trial registration: The study was retrospectively registered the 28th July 2018 in ClinicalTrials.gov register with the reference NCT03601689.

Keywords